The proportion of people with diagnosed diabetes who are receiving drug therapy has increased over time, though there were medication class trends with increased use of metformin, insulin, GLP1RA, and SGLT2i, and decreased use of thiazolidinediones and sulfonylureas. The gene discussed is INS; the disease is diabetes mellitus.